Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Equinox Gold Corp. Common Shares (EQX) vs Moderna, Inc. (MRNA) Price & Performance

Equinox Gold Corp. Common SharesTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Equinox Gold Corp. Common Shares vs Moderna, Inc. — how do they compare? Equinox Gold Corp. Common Shares trades at $11.4 (market cap $12.80B), while Moderna, Inc. trades at $196.72 (market cap $78.44B). The key difference: Moderna, Inc. is far larger — about 6.1× Equinox Gold Corp. Common Shares's market cap, and Equinox Gold Corp. Common Shares pays a 0.48% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Equinox Gold Corp. Common Shares for 0 Days and Moderna, Inc. for 59 Days on average.

EQXMRNA
Market Cap
$12.80B$78.44B
Volume
8,210,53714,597,511
Sector
Basic MaterialsHealth
52-Week High
$18.76$203.46
52-Week Low
$8.62$22.36
Typical Hold Time
0 Days59 Days
Enterprise Value
$12.90B$74.59B
Dividend Yield
0.48%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Equinox Gold Corp. Common Shares

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $197.00, up 5.09% today, with a bullish technical signal supported by moving averages. Recent inclusion in the Nasdaq-100 index has driven positive momentum, though the stock faces valuation concerns after a 500% rally in 2026. Financially, revenue has declined from $18.9B in 2022 to $1.92B in 2025, with net losses widening to -$2.82B. Earnings have consistently beaten expectations, but profitability metrics remain negative.

Outlook: Near-term upside may be capped by high valuations and profit-taking pressure, but long-term growth potential exists in the oncology pipeline. Key risks include sustained revenue declines, competitive threats, and reliance on pipeline success. Analysts are mixed, with a consensus price target of $115.70 suggesting caution despite bullish technicals.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EQX
100% Buy0% Sell
Avg holding period · 0 Days
MRNA
29% Buy71% Sell
Avg holding period · 59 Days

Top news

Latest headlines on both assets

About Equinox Gold Corp. Common Shares

Equinox Gold is a gold mining company with operations in the Americas. It produces gold and develops additional mining projects.

Read more on EQX →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA →